# TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers

> **NCT03713021** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 27 (actual)

## Conditions studied

- Oropharyngeal Cancer

## Interventions

- **DEVICE:** TraceIT Tissue Marker

## Key facts

- **NCT ID:** NCT03713021
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-15
- **Primary completion:** 2021-02-17
- **Final completion:** 2021-02-17
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Equipment unavailable
- **Last updated:** 2022-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03713021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03713021, "TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03713021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*